# Maharashtra FDA warns SRK, Ajay Devgn of Rs 10 lakh fine over Vimal ad 2026-08-18T15:41:56+00:00 | Governance | Indian Opinion Desk Corroboration: 3 independent outlets (5 source reports) Maharashtra Food and Drug Administration commissioner Tukaram Mundhe has warned that Bollywood actors Shah Rukh Khan, Ajay Devgn and Tiger Shroff could face a fine of up to Rs 10 lakh if their responses to show-cause notices over a Vimal Elaichi advertisement are unsatisfactory. The notices, issued on August 14, allege that the ad amounts to surrogate or indirect promotion of a pan masala brand, which is prohibited under the Food Safety and Standards Act, 2006. Mundhe told ANI that the FDA had been examining the matter and that action, even if delayed, was necessary. "This invites a fine up to Rs 10 lakh in the first stage," he said, adding that further action could be taken under clauses on prohibited items if the replies are not satisfactory. The actors have 15 days to respond. The FDA has also cited a state government order banning the manufacture and sale of such products for one year from July 13, 2026. The crackdown is part of a wider enforcement drive by the FDA under Mundhe. Chief minister Devendra Fadnavis has backed the drive, and deputy chief minister Eknath Shinde has directed the FDA to consider action under MCOCA against organised food adulteration. Separately, actor Mukesh Khanna has publicly backed the notices and urged the three stars to apologise. ## Indian Opinion Analysis Coverage is uniform in reporting the FDA warning but differs in framing. Times of India (sources 3 and 4) leads with Mundhe's threat of a fine and notes the ban order, sticking to straight reportage. Hindustan Times also leads with the fine and includes Mundhe's "better late than never" defence. Free Press Journal adds political backing from Fadnavis and Shinde, and flags MCOCA as a potential tool against food adulteration, giving the story a governance-action angle. Source 5 (ToI) is a separate piece quoting Mukesh Khanna's criticism of the actors. No source questions the FDA's case or notes any defence from the actors. The measured takeaway: the FDA is using high-profile enforcement to signal seriousness, but the actors' legal risk depends on their responses and whether the ad is legally proven to be surrogate promotion. ## Coverage Coverage: 5 sources, 1 pro-government, 3 neutral, 1 sensationalist - hindustantimes.com (neutral report) Straight reporting of Mundhe's warning and notice details, with no editorial slant. - freepressjournal.in (pro government) Leads with Fadnavis and Shinde backing the FDA crackdown and MCOCA option, foregrounding political support. - timesofindia.indiatimes.com (neutral report) Neutral report on Mundhe's warning and legal provisions, with no added commentary. - timesofindia.indiatimes.com (2) (neutral report) - timesofindia.indiatimes.com (3) (sensationalist) Leads with Khanna's call for apology, framing the story as celebrity controversy rather than regulation. This story was synthesised by AI from the 5 sources linked above. Updated: this story now draws on 5 sources. Last updated 2026-08-18T16:50:59+00:00. Tags: Ajay Devgn, Maharashtra FDA, Shah Rukh Khan, Tiger Shroff, Tukaram Mundhe, Vimal Canonical: https://indianopinion.org/fda-warns-srk-ajay-devgn-tiger-shroff-of-rs-10-lakh-fine-over-vimal-ad/ License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources. Cite: https://indianopinion.org/fda-warns-srk-ajay-devgn-tiger-shroff-of-rs-10-lakh-fine-over-vimal-ad/#story-in-brief How this brief was made: an AI model read the reports linked above and wrote this summary and analysis, which were published automatically. Published briefs are sampled every hour by an automated quality check; the editor verifies its findings and approves corrections, and corrected briefs carry a dated correction line. Stance labels are editorial classifications of how each outlet framed this story, assigned by the same model, not ratings of the outlets. We do no original reporting. Methodology: https://indianopinion.org/ai-use-policy/